Literature DB >> 31301876

Phosphaturic mesenchymal tumors: A review and update.

Andrew L Folpe1.   

Abstract

Perhaps the rarest cause of osteomalacia is that caused by a neoplasm, so-called "tumor-induced osteomalacia" (TIO). Although very rare cases of TIO have been associated with carcinomas and syndromes such as neurofibromatosis type-1 and McCune-Albright syndrome, the overwhelming majority of TIO is caused by tumors of mesenchymal origin. Although it was historically felt that almost any mesenchymal tumor type could occasionally result in TIO, it has become increasingly clear over the past several decades that almost all cases of mesenchymal tumor-associated TIO are caused by a single entity, known as "phosphaturic mesenchymal tumor" (PMT). This article will review historical aspects of this tumor, as well as its clinical, morphological, immunohistochemical and molecular genetic features. The distinction of PMT from its many potential morphological mimics is discussed in detail.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone tumors; FGF23; FGFR1; FN1; Osteomalacia; Phosphaturic mesenchymal tumor; Soft tissue tumors

Year:  2019        PMID: 31301876     DOI: 10.1053/j.semdp.2019.07.002

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  17 in total

Review 1.  Tumor-Induced Osteomalacia.

Authors:  Pablo Florenzano; Iris R Hartley; Macarena Jimenez; Kelly Roszko; Rachel I Gafni; Michael T Collins
Journal:  Calcif Tissue Int       Date:  2020-06-05       Impact factor: 4.333

Review 2.  Paraneoplastic musculoskeletal disorders: review and update for radiologists.

Authors:  Kimia Khalatbari Kani; Jack A Porrino; Michael E Mulligan; Felix S Chew
Journal:  Skeletal Radiol       Date:  2022-05-23       Impact factor: 2.199

3.  Phosphaturic Mesenchymal Tumor.

Authors:  J C Benson; J A Trejo-Lopez; A M Nassiri; K Eschbacher; M J Link; C L Driscoll; R D Tiegs; J Sfeir; D R DeLone
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-19       Impact factor: 4.966

Review 4.  The Causes of Hypo- and Hyperphosphatemia in Humans.

Authors:  Eugénie Koumakis; Catherine Cormier; Christian Roux; Karine Briot
Journal:  Calcif Tissue Int       Date:  2020-04-13       Impact factor: 4.333

5.  A mysterious case of recurrent fracture: Tumour-induced osteomalacia.

Authors:  Sahana Shetty; Shruthi Ravindra; Himamshu Acharya; Sharath K Rao
Journal:  J Family Med Prim Care       Date:  2022-03-10

6.  Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia.

Authors:  Juan M Colazo; Joseph A DeCorte; Erin A Gillaspie; Andrew L Folpe; Kathryn M Dahir
Journal:  Bone Rep       Date:  2020-12-24

7.  Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption.

Authors:  Naoko Hidaka; Hajime Kato; Minae Koga; Masaki Katsura; Yuko Oyama; Yuka Kinoshita; Seiji Fukumoto; Noriko Makita; Masaomi Nangaku; Nobuaki Ito
Journal:  Bone Rep       Date:  2021-10-16

8.  Diagnosis and Management of Tumor-induced Osteomalacia: Perspectives From Clinical Experience.

Authors:  Kathryn Dahir; María Belén Zanchetta; Irinel Stanciu; Cemre Robinson; Janet Y Lee; Ruban Dhaliwal; Julia Charles; Roberto Civitelli; Mary Scott Roberts; Stan Krolczyk; Thomas Weber
Journal:  J Endocr Soc       Date:  2021-06-02

9.  Molecular Profiling of Atypical Tenosynovial Giant Cell Tumors Reveals Novel Non-CSF1 Fusions.

Authors:  Theodore Vougiouklakis; Guomiao Shen; Xiaojun Feng; Syed T Hoda; George Jour
Journal:  Cancers (Basel)       Date:  2019-12-31       Impact factor: 6.639

Review 10.  Detection Rate of Culprit Tumors Causing Osteomalacia Using Somatostatin Receptor PET/CT: Systematic Review and Meta-Analysis.

Authors:  Marie Meyer; Marie Nicod Lalonde; Nathalie Testart; Mario Jreige; Christel Kamani; Sarah Boughdad; Barbara Muoio; Fabio Becce; Niklaus Schaefer; Christian Candrian; Luca Giovanella; John O Prior; Giorgio Treglia; Martin Riegger
Journal:  Diagnostics (Basel)       Date:  2019-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.